What Researchers Did
Researchers investigated the efficacy of hyperbaric oxygen therapy on haemostatic ability in 43 patients with essential haematuria over 35 days.
What They Found
Among 15 untreated patients, haematuria persisted in all but one (6.7%). For 11 patients receiving carbazochrome sodium sulfate and tranexamic acid, excellent haemostatic results were observed in 2 (18.2%). In contrast, 10 out of 17 patients (58.8%) treated with hyperbaric oxygen therapy achieved excellent results, with an additional one (5.9%) showing good results, and no serious adverse effects were noted.
What This Means for Canadian Patients
For Canadian patients experiencing essential haematuria, hyperbaric oxygen therapy could potentially offer an alternative treatment option if conventional haemostatic drugs prove ineffective. This approach might provide a beneficial outcome for those who do not respond to standard medical management.
Canadian Relevance
This study has no direct Canadian connection as it was not conducted in Canada nor involved Canadian researchers or participants.
Study Limitations
Limitations include the relatively small sample size, the short study duration, and the lack of a direct placebo-controlled comparison for hyperbaric oxygen therapy.